Table 1.
Profile of each group evaluated and comparison between the variables analyzed
| Variables | Losartan group (n = 21) | Amlodipine group (n = 21) | p-value |
|---|---|---|---|
| Age (years) | 54.0 ± 6.9 | 54.9 ± 4.5 | 0.619 |
| Female, n (%) | 15 (71.4) | 15 (71.4) | 1.000 |
| Black, n (%) | 4 (19.0) | 3 (14.3) | 0.679 |
| BMI, kg/m2 | 30.4 ± 3.5 | 29.8 ± 4.0 | 0.636 |
| Smoking, n (%) | 5 (23.8) | 6 (28.6) | 0.939 |
| Dyslipidemia, n (%) | 13 (61.9) | 12 (57.1) | 0.753 |
| Statin use, n (%) | 8 (38.1) | 6 (28.6) | 0.513 |
| ASA use, n (%) | 7 (33.3) | 7 (33.3) | 1.000 |
| Metformin use, n (%) | 18 (85.7) | 18 (85.7) | 1.000 |
| Sulfonylurea use, n (%) | 5 (23.8) | 6 (28.6) | 0.726 |
Data are expressed as mean ± standard deviation or as percentages, as indicated. ASA: acetylsalicylic acid; BMI: body mass index. The p-values were calculated using Student's t test for continuous variables and the chi-square test for categorical variables.